Evidence map›Paper›PMID 41993893›Full record

ArticleFrontiers in pediatrics2026

Management of hematogenous osteomyelitis in children in Douala, Cameroon: diagnostic challenges, complications, and perspectives for improvement.

Pauline Mantho Fopa, Prosper Mouapi, Eric R Bitchoka, Frédérique Azoo, Ritha Mbono, Théophile Kamguep, Jean Paul Engbang, Puis Fokam, Faustin Mouafo Tambo

Abstract read
In one paragraph

Article in Frontiers in pediatrics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Pauline Mantho FopaFaculty of Medicine and Pharmaceutical Sciences, University of Douala, Douala, Cameroon.
Prosper MouapiFaculty of Medicine and Pharmaceutical Sciences, University of Douala, Douala, Cameroon.
Eric R BitchokaPediatric Surgery Unit, Laquintinie Hospital of Douala, Douala, Cameroon.
Frédérique AzooGeneral Surgery Unit, Gyneco-Obstetric and Pediatric Hospital of Douala, Douala, Cameroon.
Ritha MbonoFaculty of Medicine and Pharmaceutical Sciences, University of Douala, Douala, Cameroon.
Théophile KamguepPediatric Unit, Protestant Hospital of Ndogbati, Douala, Cameroon.
Jean Paul EngbangFaculty of Medicine and Pharmaceutical Sciences, University of Douala, Douala, Cameroon.
Puis FokamGeneral Surgery Unit, Douala General Hospital, Douala, Cameroon.
Faustin Mouafo TamboFaculty of Medicine and Biomedical Sciences, University of Yaoundé I, Yaoundé, Cameroon.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Pediatric hematogenous osteomyelitis remains a major cause of morbidity in low-resource settings. In Douala, Cameroon, delayed diagnosis and comorbid conditions contribute to severe disease and unfavorable outcomes. Methods: We conducted a retrospective cross-sectional study of children aged 0-15 years diagnosed with hematogenous osteomyelitis in five referral hospitals in Douala between January 2017 and December 2024. Sociodemographic, clinical, microbiological, therapeutic, and outcome data were collected. Univariate analysis was performed using odds ratios (OR) with 95% confidence intervals (CI), and variables with Results: Among 306 pediatric osteoarticular infections, 102 were osteomyelitis and 81 met inclusion criteria. The mean age was 6.88 ± 3.98 years, with male predominance (sex ratio 1.79). Consultation was delayed beyond three months in 48.1% of cases. Blood cultures were positive in 21.6%, while focal cultures were positive in 71.1%, with Conclusion: Pediatric hematogenous osteomyelitis in Douala remains frequent and severe. Delayed consultation and sickle cell disease are major determinants of poor prognosis. Early diagnosis, strengthened microbiological capacity, and multidisciplinary management are essential to improve outcomes.

Indexed as

hematogenous infectionpediatric osteomyelitisprognostic factorssickle cell diseasesurgical management

Identifiers

PMID41993893
PMCPMC13079680

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.